Patient preferences are critical for the successful development, regulation, and reimbursement of medical products and creating patient centric decision-making within the medical product lifecycle (MPLC). This thesis identified multiple systemic challenges preventing the systematic integration of patient preference studies into the MPLC.
- PhD student
- Promotor
- Co-promotor
- Date
- Wednesday 9 Dec 2020, 13:30 - 15:00
- Type
- PhD defence
- Spoken Language
- English
- Space
- Senate Hall
- Building
- Erasmus Building
- Location
- Campus Woudestein
Greater methodological clarity is needed by key stakeholders before the information can be successfully incorporated into decision-making. Patient preferences can be measured through a variety of different preference elicitation and exploration methods and decision-makers are eager to discover which methods would be the most acceptable for market authorisation submissions or HTA/payer reimbursement decisions.
This thesis appraised several methods and conducted a head-to-head empirical study. There is no ‘gold-standard’ patient preference elicitation or exploration method, but some methods have more promising features, and are more likely to meet decision-makers needs across the MPLC, such as the discrete-choice experiment (DCE). The development of methodologically sound patient preference studies is an important field of scientific research that will benefit the lives of patients.
